GE HealthCare Technologies Inc. (NASDAQ:GEHC) Holdings Decreased by Yousif Capital Management LLC

Yousif Capital Management LLC decreased its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 10.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 57,933 shares of the company’s stock after selling 7,056 shares during the quarter. Yousif Capital Management LLC’s holdings in GE HealthCare Technologies were worth $4,479,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of the business. South Dakota Investment Council grew its holdings in shares of GE HealthCare Technologies by 272.1% during the fourth quarter. South Dakota Investment Council now owns 98,262 shares of the company’s stock valued at $7,598,000 after buying an additional 71,857 shares in the last quarter. GAMMA Investing LLC purchased a new position in shares of GE HealthCare Technologies during the fourth quarter valued at $297,000. California Public Employees Retirement System grew its holdings in shares of GE HealthCare Technologies by 1.4% during the fourth quarter. California Public Employees Retirement System now owns 845,697 shares of the company’s stock valued at $65,389,000 after buying an additional 11,746 shares in the last quarter. RWA Wealth Partners LLC purchased a new position in shares of GE HealthCare Technologies during the fourth quarter valued at $392,000. Finally, Mengis Capital Management Inc. grew its holdings in shares of GE HealthCare Technologies by 267.9% during the fourth quarter. Mengis Capital Management Inc. now owns 16,307 shares of the company’s stock valued at $1,261,000 after buying an additional 11,875 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

Shares of NASDAQ:GEHC opened at $86.24 on Friday. GE HealthCare Technologies Inc. has a fifty-two week low of $62.35 and a fifty-two week high of $94.50. The business has a 50-day moving average of $88.92 and a two-hundred day moving average of $78.45. The stock has a market capitalization of $39.35 billion, a P/E ratio of 28.56, a P/E/G ratio of 2.99 and a beta of 0.94. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.05 and a quick ratio of 0.83.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share for the quarter, topping analysts’ consensus estimates of $1.07 by $0.11. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The company had revenue of $5.20 billion during the quarter, compared to analysts’ expectations of $5.09 billion. During the same quarter in the previous year, the firm earned $1.31 earnings per share. The business’s quarterly revenue was up 5.3% compared to the same quarter last year. On average, equities research analysts predict that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be given a dividend of $0.03 per share. The ex-dividend date is Thursday, April 18th. This represents a $0.12 annualized dividend and a dividend yield of 0.14%. GE HealthCare Technologies’s dividend payout ratio is presently 3.97%.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on the company. Citigroup lifted their price target on GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a report on Wednesday, April 3rd. Argus boosted their target price on GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a research note on Monday, April 1st. HSBC started coverage on GE HealthCare Technologies in a research note on Thursday, February 15th. They issued a “buy” rating and a $100.00 target price on the stock. Morgan Stanley boosted their target price on GE HealthCare Technologies from $74.00 to $86.00 and gave the company an “equal weight” rating in a research note on Monday, February 12th. Finally, UBS Group upgraded GE HealthCare Technologies from a “sell” rating to a “neutral” rating and boosted their target price for the company from $66.00 to $88.00 in a research note on Monday, February 12th. Four equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, GE HealthCare Technologies presently has an average rating of “Moderate Buy” and an average price target of $95.09.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.